Whole Blood
Discovery Life Sciences, AllCells’ parent company, serves as the primary supplier of high-quality healthy and diseased whole blood products in addition to a variety of biospecimens suitable for a wide range of applications.
Whole human peripheral blood contains red blood cells, white blood cells, plasma, and platelets. Whole blood products are collected by venipuncture of qualified donors following IRB-approved protocols without further enrichment. Non-cellular serum, plasma products and isolated peripheral blood mononuclear cells (PBMCs) are also available.
Sourcing Whole Blood
Discovery offers access to thousands of highly characterized healthy donors and an extensive clinical network to collect diseased blood specimens. Donor demographics (age, sex, ethnic background, etc.) and clinical history information are included and additional biomarker characterization services are available to help you select biospecimens for your study-specific needs.
LEARN MORE
Pre-screening Options for GMP Collections
To expedit donor selection for GMP collections, AllCells offers customer-specific prescreening of clinical grade eligible donors via whole blood, leukapheresis or isolated mononuclear cells. This is a cost- and time-efficient mechanism for cell therapy developers to identify donors with suitable attributes who are eligible for future GMP-compliant leukopak or cryopreserved leukopak collections.
- Age, BMI, race, blood type, gender, smoking status, medications, CMV status
- HLA and KIR typing
- 9-color flow panel for immunophenotyping